Capricor Therapeutics Inc (CAPR)
Cost of Revenue
$20.36M
TTM · Period ending: · USD

CAPR Cost of Revenue
Latest reported$20.36Mperiod ending
Latest reported$20.36Mperiod ending
CAPR TTM Cost of Revenue ($0.00 → $20.36M)
TTM cost of revenue
High-resolution chart · PNG
CAPR cost of revenue history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Cost of Revenue (USD) |
|---|---|
| 20,359,098 | |
| 42,406,352 | |
| 61,321,924 | |
| 75,876,860 | |
| 67,325,629 | |
| 57,783,144 | |
| 49,968,585 | |
| 45,353,816 | |
| 33,545,949 | |
| 21,041,180 | |
| 9,940,167 | |
| 0 | |
| 0 | |
| 4,965,088 | |
| 10,080,787 | |
| 14,344,320 | |
| 16,858,235 | |
| 11,893,147 | |
| 6,777,448 | |
| 5,259,019 | |
| 5,374,371 | |
| 7,301,844 | |
| 8,457,000 | |
| 6,540,645 | |
| 3,911,378 | |
| 1,983,905 | |
| 828,749 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 2,223,278 | |
| 2,223,278 | |
| 2,223,278 | |
| 2,223,278 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 937,922 | |
| 1,261,325 | |
| 1,261,325 | |
| 1,261,325 | |
| 323,403 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 |